Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress

[1]  J. Nobrega,et al.  Brain Cytochrome Oxidase in Alzheimer's Disease , 1992, Journal of neurochemistry.

[2]  M. Borsaru,et al.  Neutron activation analysis , 1972 .

[3]  R. Katzman.,et al.  Editorial: The prevalence and malignancy of Alzheimer disease. A major killer. , 1976, Archives of neurology.

[4]  Maitland Ct.  Hospitals in the United States. , 1948, Lancet.

[5]  R. Bucala,et al.  Advanced glycation end products contribute to amyloidosis in Alzheimer disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[6]  R. Mohs,et al.  Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. , 2002, Psychopharmacology bulletin.

[7]  W. D. Ehmann,et al.  182 BRAIN TRACE ELEMENT LEVELS IN ALZHEIMERʼS DISEASE BY INSTRUMENTAL NEUTRON ACTIVATION ANALYSIS , 1981 .

[8]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[9]  W. D. Ehmann,et al.  RNAA for arsenic, cadmium, copper, and molybdenum in CNS tissues from subjects with age-related neurodegenerative diseases , 1994 .

[10]  W. D. Ehmann,et al.  Determination of trace elements in biological standard kale by neutron activation analysis , 1969 .

[11]  S. Landsberger,et al.  Design of a GeNaI(Tl) Compton suppression spectrometer and its use in neutron activation analysis , 1990 .

[12]  C. W. Scott,et al.  Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[13]  W. D. Ehmann,et al.  Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease , 1995, Neurology.

[14]  C. Masters,et al.  Rapid induction of Alzheimer A beta amyloid formation by zinc. , 1994, Science.

[15]  J. Coyle,et al.  Oxidative stress, glutamate, and neurodegenerative disorders. , 1993, Science.

[16]  B. Weiss,et al.  Food additives as a source of behavioral disturbances in children. , 1986, Neurotoxicology.

[17]  W. D. Ehmann,et al.  Elemental imbalances in the olfactory pathway in Alzheimer's disease , 1995, Journal of the Neurological Sciences.

[18]  J. Ávila,et al.  Analysis of microtubule-associated protein tau glycation in paired helical filaments. , 1994, The Journal of biological chemistry.

[19]  Patrizia Mecocci,et al.  Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease , 1994, Annals of neurology.

[20]  R. Domínguez,et al.  Copper-zinc superoxide dismutase activity in red blood cells and serum in demented patients and in aging , 1993, Journal of the Neurological Sciences.

[21]  S. M. Sumi,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.

[22]  C. Masters,et al.  The Amyloid Precursor Protein of Alzheimer's Disease in the Reduction of Copper(II) to Copper(I) , 1996, Science.

[23]  S. Aust,et al.  Ferritin and ceruloplasmin in oxidative damage: review and recent findings. , 1993, Canadian journal of physiology and pharmacology.

[24]  L. Goodman.  Alzheimer's disease; a clinico-pathologic analysis of twenty-three cases with a theory on pathogenesis. , 1953, The Journal of nervous and mental disease.

[25]  R. Terry,et al.  Senile dementia of the Alzheimer type , 1983, Annals of neurology.

[26]  Ferritin: isolation of aluminum-ferritin complex from brain. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[27]  B T Hyman,et al.  Functional Alterations in Alzheimer's Disease: Diminution of Cytochrome Oxidase in the Hippocampal Formation , 1993, Journal of neuropathology and experimental neurology.

[28]  A. Burns.  Clinical diagnosis of Alzheimer's disease , 1991 .

[29]  J. Connor,et al.  Ceruloplasmin levels in the human superior temporal gyrus in aging and Alzheimer's disease , 1993, Neuroscience Letters.

[30]  C. Olanow.  A radical hypothesis for neurodegeneration , 1993, Trends in Neurosciences.

[31]  W. D. Ehmann,et al.  Non-destructive analysis of copper in human brain tissue by neutron activation analysis using coincidence and anti-coincidence techniques , 1997 .

[32]  W. D. Ehmann,et al.  Regional brain trace-element studies in Alzheimer's disease. , 1988, Neurotoxicology.

[33]  S. Rapoport,et al.  Impairment in mitochondrial cytochrome oxidase gene expression in Alzheimer disease. , 1994, Brain research. Molecular brain research.

[34]  W. Markesbery,et al.  Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[35]  M. Mattson,et al.  β-Amyloid Peptide Free Radical Fragments Initiate Synaptosomal Lipoperoxidation in a Sequence-Specific Fashion: Implications to Alzheimer′s Disease , 1994 .

[36]  M. Mattson,et al.  A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[37]  W. D. Ehmann,et al.  Brain trace elements in Alzheimer's disease. , 1986, Neurotoxicology.

[38]  R. Domínguez,et al.  Copper-zinc superoxide dismutase activity in red blood cells in probable Alzheimer's patients and their first-degree relatives , 1994, Journal of the Neurological Sciences.

[39]  D. Walker,et al.  Lactotransferrin immunocytochemistry in Alzheimer and normal human brain. , 1993, The American journal of pathology.

[40]  D. Perl,et al.  Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: A laser microprobe (LAMMA) study , 1992, Annals of neurology.

[41]  D. Miller,et al.  Effects of ceruloplasmin on superoxide-dependent iron release from ferritin and lipid peroxidation. , 1991, Free radical research communications.

[42]  Z. Khachaturian.  Diagnosis of Alzheimer's disease. , 1985, Archives of neurology.

[43]  J. Gutteridge,et al.  Antioxidant protection against organic and inorganic oxygen radicals by normal human plasma: the important primary role for iron-binding and iron-oxidising proteins. , 1992, Biochimica et biophysica acta.

[44]  N. Ward,et al.  Neutron activation analysis techniques for identifying elemental status in Alzheimer's disease , 1987 .

[45]  W. D. Ehmann,et al.  Instrumental neutron activation analysis of brain aluminum in Alzheimer disease and aging , 1981, Annals of neurology.

[46]  F. Burnet.  A POSSIBLE ROLE OF ZINC IN THE PATHOLOGY OF DEMENTIA , 1981, The Lancet.

[47]  R. Webster,et al.  Ceruloplasmin inhibits carbonyl formation in endogenous cell proteins. , 1993, Free radical biology & medicine.

[48]  M. Beal,et al.  Cortical Cytochrome Oxidase Activity Is Reduced in Alzheimer's Disease , 1994, Journal of neurochemistry.